| Financial Year |
March 31 2023 |
| Monetary Funds |
2,887,607,196.64 |
| Held-for-trading Financial Assets |
16,842,367.66 |
| Notes Receivable |
54,822,705.29 |
| Accounts Receivable |
2,367,987,858.03 |
| Advances to Suppliers |
217,126,625.92 |
| Other Receivables |
93,970,928.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
255,388,262.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,260,083.09 |
| Other Current Assets |
292,691,188.53 |
| Total Current Assets |
6,227,777,284.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,032,140.25 |
| Investment Properties |
48,230,054.30 |
| Fixed Assetes |
443,669,113.56 |
| Under-construction Projects |
1,835,633.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,303,947.88 |
| R&D expenses |
45,869,969.72 |
| Goodwill |
134,634,838.96 |
| Long-Term Deferred and Prepaid Expenses |
12,338,524.71 |
| Deferred Income Tax Assets |
152,624,676.80 |
| Other Non-Current Assets |
31,069,883.49 |
| Sub-Total of Non-Current Assets |
1,243,403,664.42 |
| Total Assets |
7,471,180,949.16 |
| Short-Term Loans |
517,585,683.90 |
| Trading Financial liabilities |
715,122.20 |
| Notes Payable |
2,071,709,536.50 |
| Accounts Payable |
1,439,886,836.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,262,849.70 |
| Taxes Payable |
32,195,210.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,675,288.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,208,919.86 |
| Other Current Liabilities |
33,292,950.57 |
| Sub-Total of Current Liabilities |
4,303,303,865.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,844,217.01 |
| Other Non-Current Liabilities |
26,545,424.65 |
| Sub-Total of Non-Current Liabilities |
54,592,921.50 |
| Total Liabilities |
4,357,896,786.68 |
| Paid-In Capital(Or Share Stock) |
721,307,933.00 |
| Capital Surplus |
1,985,979,245.14 |
| Surplus Reserve |
98,462,216.13 |
| LESS:Treasury Stock |
59,481,058.78 |
| Undistributed Profits |
407,529,635.07 |
| Minority Stockholder's Interest |
8,415,777.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,104,868,385.07 |
| Owner's Equity（Stockholder's Equity） |
3,113,284,162.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,471,180,949.16 |
